The m6A methyltransferase METTL5 promotes neutrophil extracellular trap network release to regulate hepatocellular carcinoma progression
Abstract Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide, it has a poor prognosis due to its highly invasive and metastatic nature. Consequently, identifying effective prognostic markers and potential therapeutic targets has been extensively investigate...
Main Authors: | Qi Wang, Yuxi Huang, Yu Zhu, Wenlong Zhang, Binfeng Wang, Xuefeng Du, Qiqiang Dai, Fabiao Zhang, Zheping Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-04-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.7165 |
Similar Items
-
The novel putative methyltransferase METTL7A as one prognostic biomarker potentially associated with immune infiltration in human renal cancer
by: Zhiqian Yang, et al.
Published: (2023-04-01) -
Roles of the m6A methyltransferases METTL3, METTL14, and WTAP in pulmonary tuberculosis
by: Tian-Ping Zhang, et al.
Published: (2022-12-01) -
RNA Binding by the m6A Methyltransferases METTL16 and METTL3
by: Kyle D. Mansfield
Published: (2024-05-01) -
METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma
by: Jialin Wang, et al.
Published: (2024-09-01) -
A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment
by: Zhongji Jiang, et al.
Published: (2022-10-01)